| A blood atlas of COVID-19 defines hallmarks of disease severity and specificity COMBATC Consortium Cell 185 (5), 916-938, 2022 | 159 | 2022 |
| Human bone marrow organoids for disease modeling, discovery, and validation of therapeutic targets in hematologic malignancies AO Khan, A Rodriguez-Romera, JS Reyat, AA Olijnik, M Colombo, ... Cancer discovery 13 (2), 364-385, 2023 | 39 | 2023 |
| Impaired antibody response to COVID‐19 vaccination in patients with chronic myeloid neoplasms O Chowdhury, H Bruguier, G Mallett, N Sousos, K Crozier, C Allman, ... British Journal of Haematology 194 (6), 1010, 2021 | 33 | 2021 |
| In utero origin of myelofibrosis presenting in adult monozygotic twins N Sousos, M Ní Leathlobhair, C Simoglou Karali, E Louka, N Bienz, ... Nature Medicine 28 (6), 1207-1211, 2022 | 29 | 2022 |
| A novel molecular magnetic resonance imaging agent targeting activated leukocyte cell adhesion molecule as demonstrated in mouse brain metastasis models N Zarghami, MS Soto, F Perez-Balderas, AA Khrapitchev, CS Karali, ... Journal of Cerebral Blood Flow & Metabolism 41 (7), 1592-1607, 2021 | 16 | 2021 |
| Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19 CP Kotanidis, C Xie, D Alexander, JCL Rodrigues, K Burnham, A Mentzer, ... The Lancet Digital Health 4 (10), e705-e716, 2022 | 12 | 2022 |
| Epigenetic potentiation of somatostatin-2 by guadecitabine in neuroendocrine neoplasias as a novel method to allow delivery of peptide receptor radiotherapy JS Evans, J Beaumont, M Braga, N Masrour, F Mauri, A Beckley, S Butt, ... European Journal of Cancer 176, 110-120, 2022 | 8 | 2022 |
| Selective blood-brain barrier permeabilization of brain metastases by a type 1 receptor-selective tumor necrosis factor mutein MF Munoz Pinto, SJ Campbell, C Simoglou Karali, VA Johanssen, ... Neuro-oncology 24 (1), 52-63, 2022 | 7 | 2022 |
| A pro-inflammatory stem cell niche drives myelofibrosis through a targetable galectin 1 axis R Li, M Colombo, G Wang, A Rodriguez-Romera, J O'Sullivan, SA Clark, ... bioRxiv, 2023.08. 05.550630, 2023 | 3 | 2023 |
| Abstracts from the 20th international symposium on signal transduction at the blood-brain barriers A Małecki, J Skipor-Lahuta, M Toborek, NJ Abbott, DA Antonetti, EJ Su, ... Fluids and Barriers of the CNS 14, 1-23, 2017 | 2 | 2017 |
| Modelling the pathology and treatment of cardiac fibrosis in vascularised atrial and ventricular cardiac microtissues JS Reyat, A di Maio, B Grygielska, J Pike, S Kemble, ... Frontiers in cardiovascular medicine 10, 1156759, 2023 | 1 | 2023 |
| Rapamycin Treatment Reduces Brain Pericyte Constriction in Ischemic Stroke D Beard, LS Brown, GP Morris, Y Couch, BA Adriaanse, ... bioRxiv, 2024.03. 18.584333, 2024 | | 2024 |
| Cooperation between SF3B1 and JAK2 V617F Mutations Accelerates Fibrotic Progression in Myeloproliferative Neoplasms By Enhancing STAT1 Signaling JO Sullivan, S Wen, A Aliouat, A Rodriguez-Meira, SA Clark, N Ashley, ... Blood 142, 861, 2023 | | 2023 |
| Platelets Sequester Extracellular DNA, Capturing Tumour-Derived and Free Fetal DNA L Murphy, J Inchauspe, N Sousos, N Jooss, HL Belnoue-Davis, P Holland, ... Blood 142, 277, 2023 | | 2023 |
| Platelet-Restricted Clonal Hematopoiesis N Sousos, L Murphy, S Wen, A Hamblin, SA Clark, CS Karali, J Whittle, ... Blood 142, 814, 2023 | | 2023 |
| A Multiomic Single-Cell Atlas of Human Myelopoiesis Reveals Cellular and Molecular Drivers of Immunomodulatory Drug-Induced Neutropenia C Simoglou Karali, S Riva, SA Clark, S Wen, N Sousos, E Louka, ER Gür, ... Blood 142 (Supplement 1), 935-935, 2023 | | 2023 |
| Cross-Talk between Hematopoietic Cells and Fibroblast Subsets Drives Inflammation and Remodelling of the Bone Marrow Microenvironment in Myeloproliferative Neoplasms R Li, M Colombo, G Wang, SA Clark, A Rodriguez-Romera, Y Meng, ... Blood 140 (Supplement 1), 1091-1092, 2022 | | 2022 |
| A blood atlas of COVID-19 defines hallmarks of disease severity and specificity (preprint) DJ Ahern, Z Ai, M Ainsworth, C Allan, A Allcock, A Ansari, ... | | 2021 |
| The Sticky Wicket of Undruggable Mutations: Can Targeted Molecular Degradation Help? CS Karali, A Mead The Hematologist 17 (5), 2020 | | 2020 |
| Selective permeabilisation of the blood-brain barrier during brain metastasis via TNFR1 C Karali University of Oxford, 2018 | | 2018 |
